If the stock closes at or above $10 at expiration this trade will return 22.69% or 22.21% (for comparison purposes only). ARRY closed Jan 9, 2018's trading session at $13.55. In the past year, the stock has hit a 52-week low of $6.73 and 52 …
Array BioPharma Inc. ARRY was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the …
Its proprietary clinical programs include ARRY-520, a kinesin spindle protein inhibitor, which is in Phase II clinical trial for patients with multiple myeloma. The Jefferies price target for the stock is set at $8. The Thomson/First Call estimate is …
The 2024 Notes, any shares of common stock issuable upon conversion of the ... The post Array BioPharma Inc. (NASDAQ:ARRY) Files An 8-K Entry into a Material Definitive Agreement appeared first on Market Exclusive. …
ARRY closed Tuesday's trading at $7.02, up 0.86%. In after-hours, the stock was up 11.40% to $7.82. Shares of Depomed Inc. (DEPO) plunged more than 13% in after-hours on Tuesday as the Company's first quarter earnings and revenue fell …
ARRY-797 is currently in Phase 2 trials for patients with a ... They closed at $12.51 on Tuesday. Array's stock is up 40-plus percent for the year, following announcements of partnerships with Pfizer, Bristol-Myers Squibb and Merck, as well …
Investors in Array BioPharma Inc. ARRY need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2017 $5.00 Put had some of the highest implied volatility of all equity options today. …
Investors in Array BioPharma Inc. ARRY need to pay close attention to the stock based on moves in the options market lately. That is because the April 21 st, 2017 $13 Put had some of the highest implied volatility of all equity options …
Array BioPharma Inc. ARRY was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked …